Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Adductor canal catheter refers to a regional anesthesia technique and medical device setup used for the continuous delivery of local anesthetics, such as ropivacaine, to provide postoperative pain relief. Specifically studied by the University of British Columbia in the context of total knee arthroplasty (TKA), the technique involves placing a catheter within the adductor canal to target the saphenous nerve and other sensory branches. This approach aims to provide effective analgesia while minimizing motor blockade of the quadriceps muscle, thereby facilitating earlier patient mobilization compared to traditional femoral nerve blocks. In clinical trials (NCT02798835), this continuous infusion method was compared against single-injection adductor canal blocks to evaluate its non-inferiority in opioid consumption and pain scores.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Adductor canal catheter.